Bridgebio Pharma, Inc. trades by members of Congress

Purchases and sales of Bridgebio Pharma, Inc. shares that members of the House have disclosed since January 3, 2015, with the value range each one reported and a link to the original filing.

Purchases, last 12 months 5 trades Reported value $5,005–$75,000 (sum of the ranges filed)

Sales, last 12 months 1 trade Reported value $1,001–$15,000 (sum of the ranges filed)

Members trading, last 12 months 1 8 purchases and sales since January 3, 2015

Bridgebio Pharma, Inc. trades disclosed by members of Congress
				Report
Gilbert Ray Cisneros, Jr. House · D-CA 31	Sale (partial)$1,001 - $15,000	Oct 12, 2026	Sep 29, 2026	Filing for BBIO on Sep 29, 2026
Gilbert Ray Cisneros, Jr. House · D-CA 31	Purchase$1,001 - $15,000	Jun 8, 2026	May 11, 2026	Filing for BBIO on May 11, 2026
Gilbert Ray Cisneros, Jr. House · D-CA 31	Purchase$1,001 - $15,000	May 8, 2026	Apr 29, 2026	Filing for BBIO on Apr 29, 2026
Gilbert Ray Cisneros, Jr. House · D-CA 31	Purchase$1,001 - $15,000	Apr 7, 2026	Mar 19, 2026	Filing for BBIO on Mar 19, 2026
Gilbert Ray Cisneros, Jr. House · D-CA 31	Purchase$1,001 - $15,000	Apr 7, 2026	Mar 18, 2026	Filing for BBIO on Mar 18, 2026
Gilbert Ray Cisneros, Jr. House · D-CA 31	Purchase$1,001 - $15,000	Apr 7, 2026	Mar 3, 2026	Filing for BBIO on Mar 3, 2026
Gilbert Ray Cisneros, Jr. House · D-CA 31	Purchase$1,001 - $15,000	Oct 10, 2025	Sep 22, 2025	Filing for BBIO on Sep 22, 2025
Gilbert Ray Cisneros, Jr. House · D-CA 31	Purchase$1,001 - $15,000	Sep 12, 2025	Aug 8, 2025	Filing for BBIO on Aug 8, 2025

Source: periodic transaction reports filed with the Clerk of the House of Representatives under the STOCK Act (Senate reports are not included yet). Members report trades by themselves, their spouses and dependent children. Amounts are the value ranges as filed, not exact figures, and a report can be filed up to 45 days after the trade, so the latest trades may not appear yet. Scanned paper reports are linked but not transcribed. By law (5 U.S.C. §13107) these reports may not be used for any commercial purpose other than by news and communications media for dissemination to the general public; we publish them free, as news.

← Back to Bridgebio Pharma, Inc. · Insider trading · Funds · All trades by members of Congress